Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt

Abstract

Background The population of Egypt has a heavy burden of liver disease, mostly due to chronic infection with hepatitis C virus (HCV). Overall prevalence of antibody to HCV in the general population is around 15-20%. The risk factor for HCV transmission that specifically sets Egypt apart from other countries is a personal history of parenteral antischistosomal therapy (PAT). A review of the Egyptian PAT mass-treatment campaigns, discontinued only in the 1980s, show a very high potential for transmission of blood-borne pathogens. We examine the relative importance of PAT in the spread of HCV in Egypt. Methods The degree of exposure to PAT by cohort was estimated from 1961-86 Ministry of Health data. A cohort-specific exposure index for PAT was calculated and compared with cohort-specific HCV prevalence rates in four regions. Findings HCV prevalence was calculated for 8499 Egyptians aged 10-50 years. A significant association between seroprevalence of antibodies to HCV and the exposure index (1.31 [95% CI 1.08-1.59]; p=0.007) was identified across four different regions. In all regions cohort-specific HCV prevalence was lowest in children and young adults than in older cohorts. These lower prevalence rates coincided with the gradual and final replacement of PAT with oral antischistosomal drugs at different points in time in the four regions. Interpretation The data suggest that PAT had a major role in the spread of HCV throughout Egypt. This intensive transmission established a…

Overview

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(99)06527-7

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 25 references

Cited by

See all 1,131

Metadata

Authors
Frank, C., Mohamed, M. K., Strickland, G. T., Lavanchy, D., Arthur, R. R., Magder, L. S., Khoby, T. E., Abdel-Wahab, Y., Ohn, E. S. A., Anwar, W., & Sallam, I.
Affiliations
  • University of Maryland, Baltimore (US)
  • Ain Shams University (EG)
  • World Health Organization (CH)
  • Ministry of Health and Population (EG)
Corresponding author
Strickland, G Thomas
Venue
The Lancet
Publisher
Elsevier BV
Published
2000-03
Volume
355
Issue
9207
Pages
887-891
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W2078145079
Cited by
1,131
References
25
Citations by year
2026: 8 · 2025: 10 · 2024: 22 · 2023: 24 · 2022: 22 · 2021: 28 · 2020: 34 · 2019: 33 · 2018: 50 · 2017: 55 · 2016: 53 · 2015: 62 · 2014: 75 · 2013: 74 · 2012: 67
FWCI
25.70
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • The Lancet (publishedVersion)
  • PubMed (publishedVersion)
Funders
Department for International Development, UK Government
Topics
  • Health Sciences › Medicine › Hepatology › Hepatitis C virus research
  • Life Sciences › Immunology and Microbiology › Parasitology › Parasites and Host Interactions
  • Health Sciences › Medicine › Hepatology › Hepatitis Viruses Studies and Epidemiology
Keywords
hepatitis C virus, iatrogenic transmission, bloodborne pathogens, schistosomiasis, HCV seroprevalence, chronic hepatitis C, Egypt, transmission risk factors
MeSH terms
Adolescent, Adult, Aged, Child, Child, Preschool, Egypt, Female, Hepatitis C, Humans, Infant, Injections, Intravenous, Male, Middle Aged, Risk Factors, Schistosomiasis, Schistosomicides, Cohort Studies, Blood-Borne Pathogens

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. https://app.cochat.ai/papers/10.1016/s0140-6736(99)06527-7
The paper
Frank, C., Mohamed, M. K., Strickland, G. T., Lavanchy, D., Arthur, R. R., Magder, L. S., Khoby, T. E., Abdel-Wahab, Y., Ohn, E. S. A., Anwar, W., & Sallam, I. (2000). The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. The Lancet. https://doi.org/10.1016/s0140-6736(99)06527-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.